Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2016/V13/I9/570

[1] Akman C I, Cracco J. Intrauterine subdural hemorrhage[J]. Dev Med Child Neurol, 2000, 42(12):843-846.
[2] Hassouna A, Allam H. Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis[J]. Interact Cardiovasc Thorac Surg, 2014, 18(6):797-806.
[3] Malik H T, Sepehripour A H, Shipolini A R, et al. Is there a suitable method of anticoagulation in pregnant patients with mechanical prosthetic heart valves?[J] Interact Cardiovasc Thorac Surg, 2012, 15(3):484-488.
[4] Masamoto H, Uehara H, Mekaru K, et al. Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report[J]. Am J Perinatol, 2009, 26(8):597-600.
[5] Lee H C, Cho S Y, Lee H J, et al. Warfarin-associated fetal intracranial hemorrhage: a case report[J]. J Korean Med Sci, 2003,18(5):764-767.
[6] Matsuda Y, Hashiguchi K, Akizawa Y, et al. A case of fetal subdural hematoma at 31 weeks of gestation in a woman on warfarin therapy after Cabrol’s operation[J]. Fetal Diagn Ther, 2003,18(4): 252-254.
[7] Oswal K, Agarwal A. Warfarin-induced fetal intracranial subdural hematoma[J]. J Clin Ultrasound, 2008, 36(7):451-453.
[8] 方洁, 王心, 尚丽新. 妊娠晚期胎儿颅内出血1例报告[J]. 中国实用妇科与产科杂志, 2014, 30(4): 312-313.
[9] Srivastava A R, Modi P, Sahi S, et al. Anticoagulation for pregnant patients[J]. Ann Card Anaesth, 2007, 10(2):95-107.
[10] Castellano J M, Narayan R L, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve[J]. Nat Rev Cardiol, 2012, 9(7):415-24.
[11] Salazar E, Espinola N, Roman L, et al. Effect of pregnancy on the duration of bovine pericardial bioprostheses[J]. Am Heart J, 2000,139(5): 924-925.
[12] Nishimura R A, Otto C M, Bonow R O, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2014, 63(22):e57-185.
[13] Basude S, Hein C, Curtis S L, et al. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study[J]. BJOG, 2012, 119(8):1008-1013.
[14] Yinon Y, Siu S C, Warshafsky C, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves[J]. Am J Cardiol, 2009, 104(9):1259-1263.
[15] Quinn J, Von Klemperer K, Brooks R, et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience[J]. Haematologica, 2009, 94(11):1608-1612.
[16] 王曦林,余海清,舒红利. 华法林与有关药物的相互作用及安全应用研究[J]. 中国社区医师, 2016, 32(2):13-14.
[17] 段福彦. 华法林的相互作用及安全应用研究[J]. 中国卫生标准管理, 2014, 5(13):58-59.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.